Astrana Health initiated with an Equal Weight at Barclays

Barclays initiated coverage of Astrana Health (ASTH) with an Equal Weight rating and $36 price target The company is well positioned to capture improving rates in the government sector, but the scale and complexity of the pending Prospect deal tempers excitement, the analyst tells investors in a research note. The firm believes the near-term execution risks are real given the scale. As such, it comes out on the sidelines.